Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 May 6;22(Suppl 1):72.
doi: 10.1186/s12954-025-01213-z.

Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals

Affiliations
Randomized Controlled Trial

Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals

Linda Peng et al. Harm Reduct J. .

Abstract

Background: Novel strategies are needed to engage people who use stimulants into the continuum of addiction care. Contingency management (CM) is the most effective intervention for stimulant use disorder and may engage non-treatment-seeking populations, especially when delivered by peer recovery support specialists (peers). We describe development and training for a novel peer-delivered CM program for stimulant use harm reduction and treatment engagement.

Methods: We used a community based participatory research (CBPR) process to develop a CM program focused on self-identified goals for harm reduction and treatment engagement. A steering committee of peers guided study design, CM rewards, schedule, and incentivized goals. Peers completed coaching-to-criterion of six CM skills based on the CM Competence Scale (CMCS), then completed a one-on-one roleplay with a standardized patient. Coaches rated peer performance of each CMCS skill according to its Likert scale (1 = Very Poor to 7 = Excellent) and an a priori rating criterion of 4 ('adequate'). Roleplays included feedback and a 'replay' of skills, if necessary.

Results: The steering committee devised two CM interventions: an enhanced standard-of-care incentivizing peer visits ($20 for weekly peer visits) and an intervention that additionally incentivized self-directed goals ($20 for weekly peer visits and $30 for completed goal-related activities). Self-identified goal-related activities were chosen through a collaborative process and organized into 6 domains: (1) overdose/overamping prevention (2) substance use supports/treatment (3) daily living/housing (4) education/employment (5) mental/physical/spiritual health (6) social relationships. Forty-seven peers across nine peer-led organizations (three rural and six urban organizations across Oregon) completed CM training. All 47 peers met the a priori criterion in their roleplay, with seventeen (36%) requiring a 'replay' of a skill. Mean CMSC summary scores were 28.51 (SD 4.73) on the first attempt and 29.62 (SD 4.01) on the second attempt.

Conclusions: PEER-CM (Peers Expanding Engagement in Stimulant Harm Reduction with Contingency Management) is among the first trials to use peer-delivered CM for stimulant use, incentivizing peer engagement and self-identified goals for harm reduction and treatment engagement. A CBPR approach strengthened the study design by incorporating peer guidance. Peers in this large, multisite sample demonstrated adequate CM delivery skills with acceptable fidelity following training. Trial Registration This study is registered at ClinicalTrials.gov (NCT05700994). Registered 26 January, 2023.

Keywords: Behavior therapy; Community-based participatory research; Methamphetamine; Motivation; Psychosocial intervention; Reinforcement; Stimulants; Substance-related disorders.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was approved by the Oregon Health & Science Institutional Review Board (IRB #24672). Consent for publication: Not applicable. Availability of data and materials: The data supporting the conclusions of this article are available upon request to Linda Peng, pengli@ohsu.edu. Competing interests: The authors declare that they have no competing interests.

Similar articles

Cited by

References

    1. Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, et al. COVID-19 during the opioid epidemic—exacerbation of stigma and vulnerabilities. J Rural Health. 2021;37:172–4. - PMC - PubMed
    1. Gladden RM, O’Donnell J, Mattson CL, Seth P. Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine—25 States, July–December 2017 to January–June 2018. MMWR Morb Mortal Wkly Rep. 2019;68:737–44. - PMC - PubMed
    1. Spencer MR, Garnett MF, Miniño AM. Drug Overdose Deaths in the United States, 2002–2022. National Center for Health Statistics. 2024. https://www.cdc.gov/nchs/products/databriefs/db491.htm. Accessed 3 May 2024.
    1. Vital Statistics Rapid Release-Provisional Drug Overdose Data. Centers for Disease Control and Prevention. 2024. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 3 May 2024.
    1. Oregon Health Authority Public Health Division. Opioid Overdose Public Health Surveillance Update April 25th, 2024. Oregon Health Authority; April 25 2024.

Publication types

Associated data